Research

Cooper University Health Care’s Innovation Center has received a $70,000 grant from the New Jersey Health Foundation (NJHF) to study a new wearable heart monitor for the early detection of congestive heart failure.

The novel device, invented and developed over several years by Robert A. Hirsh, MD, a member of the Anesthesiology Department at Cooper and associate professor of clinical anesthesiology at Cooper Medical School of Rowan University, has the potential to provide an “early warning” and pre-symptom diagnosis and prevention for those at risk of congestive heart failure. Read more.

In a new study published recently in Nutrients, a peer-reviewed journal of human nutrition, researchers at Cooper University Health Care found that Vitamin D supplementation can reduce the incidence of influenza-like illness in populations at risk.

The study, funded by the Won Sook Chung Foundation, was conceived during the COVID-19 pandemic  to help prevent viral infections in health care workers. Read more.

Internationally known stroke expert Tudor Jovin, MD, medical director of the Cooper Neurological Institute at Cooper University Health Care and professor of neurology and neurological surgery at Cooper Medical School of Rowan University, is co-principal investigator and lead author of a study published today in The New England Journal of Medicine, one of the world’s leading medical journals. Read more.

Wissam Abouzgheib, MD, chief of pulmonary medicine at Cooper University Health Care, is participating in a clinical study investigating a new device treatment for chronic obstructive pulmonary disease (COPD) with chronic bronchitis. Cooper is the 20^th site nationally participating in the study.

COPD is a long-term, progressive, irreversible lung disease that, over time, makes it difficult to breathe. Chronic bronchitis (CB), the largest subset of COPD, is characterized by a chronic productive cough. Read more.